Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AKTX Akari Therapeutics PLC

Not Yet Opened 08-17 16:00:00 EDT

7.52

-0.02

-0.27%

盘后7.52

+0.000.00%

17:56 EDT

High8.10	Low7.04	Vol154.73K
Open7.68	D1 Closing7.54	Amplitude14.04%
Mkt Cap14.64M	Tradable Cap5.22M	Total Shares1.95M
T/O1.19M	T/O Rate22.28%	Tradable Shares694.50K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AKTX","market":"US","secType":"STK","nameCN":"Akari Therapeutics PLC","latestPrice":7.52,"timestamp":1786996800000,"preClose":7.54,"halted":0,"volume":154730,"hourTrading":{"tag":"盘后","latestPrice":7.52,"preClose":7.52,"latestTime":"17:56 EDT","volume":64,"amount":505.58,"timestamp":1787003766687,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0026525198938992657,"floatShares":694500,"shares":1947000,"eps":-16.023678,"marketStatus":"Not Yet Opened","change":-0.02,"latestTime":"08-17 16:00:00 EDT","open":7.68,"high":8.1,"low":7.0412,"amount":1187457.235171,"amplitude":0.140424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-16.023678,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787040000000},"marketStatusCode":0,"adr":1,"adrRate":2000,"exchange":"NASDAQ","adjPreClose":7.54,"postHourTrading":{"tag":"盘后","latestPrice":7.52,"preClose":7.52,"latestTime":"17:56 EDT","volume":64,"amount":505.58,"timestamp":1787003766687,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.685492,"impliedVol":1.3123,"impliedVolPercentile":0.6222},"requestUrl":"/m/hq/s/AKTX/wiki","defaultTab":"wiki","newsList":[{"id":"2660323436","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:12","pubTimestamp":1786979555,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and DBV Technologies , which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia  and biopharmaceutical company Cellectis , which advanced 2.5% and 2% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and internet browser company Opera , which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which lost 2.4% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and biopharmaceutical company Akari Therapeutics , which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK  and Bicycle","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4532","BK4009","BK4505","BK4139","DBVT","ULVR.UK","UN","IE00BMPRXN33.USD","BK4169","IEUR","EPV","GSKH","IE0002141913.USD","OPRA","BUD.AU","MREO","DEO","IE00BFTCPJ56.SGD","DGE.UK","AKTX","ARGX","LU0006061336.USD","IE00B4R5TH58.HKD","NOK","GSK","IE00BJJMRZ35.SGD","BK4117","NCNA","AUTL","LU1983260115.SGD","AFG","BK4592","TBXU","BCYC","BK4007","FMED","IBB","LNOK","CLLS","FOCL","BUD","GSK.UK","LFGY","LU0823416689.USD","UL","WPP","LU0889565916.HKD","WPP.AU","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140268","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140268","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140268?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:08","pubTimestamp":1786720082,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the we","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","AUTL","IE0009355771.USD","ERX","LU0320765646.SGD","TBXU","EQNR","SHEH","VDE","DRLL","LU0889565916.HKD","NCNA","WTIU","SQNS","BK4107","GUSH","AFG","FMED","BPH","LNOK","BK4201","BCYC","FTXN","NOK","EPV","ARGX","SHEL","DBC","CLLS","IXC","IEUR","TRIB","BK4547","XES","BP","DBVT","PXE","DBE","IBB","DRIP","E","BDRX","USE","EVAX","IEO","AKTX","LU2324357040.USD","DIG","PXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659219198","title":"UK's Akari Therapeutics Q2 Net Loss Widens on Higher R&D for AKTX-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2659219198","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659219198?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:33","pubTimestamp":1786656795,"startTime":"0","endTime":"0","summary":"UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101OverviewUK-US oncology biotech's Q2 net loss widened yr/yr as R&D spending increasedCompany raised $8.6 mln in financing during Q2,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A1AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADCT","BK4148","BK4505","AKTX","AKTS","BK4139","BK4007","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160617","title":"Akari Therapeutics PLC Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160617","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160617?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:50","pubTimestamp":1786654245,"startTime":"0","endTime":"0","summary":"Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings SummaryAkari Therapeutics PLCAKTX.OQreported a quarterly adjusted loss of $2.68 per share for the quarter ended June 30,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A27C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659082162","title":"Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of Aktx-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2659082162","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659082162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA3G8651:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659678961","title":"Press Release: Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2659678961","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659678961?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"million in gross proeeds, and warrant exercises worth $3.1 million in. gross proceeds for a total of approximately $8.6 million in gross. proceeds from financing in the quarter, resulting in approximately $8.0. -- Continued advancing AKTX-101 through IND-enabling activities by. progressing manufacturing and development work to enable the Phase 1. clinical trial. The Company remains focused on initiating AKTX-101 for. -- Expanded the Company's strategic position in novel ADC payloads through a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","PRGS","BK4080","LU2065732104.USD","AKTX","NETL","BK4007","ADC","BK4139","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659016285","title":"Akari Net Loss Widens to $4.81 Million in Q2 FY26; Operating Loss Rises to $4.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659016285","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659016285?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:04","pubTimestamp":1786651489,"startTime":"0","endTime":"0","summary":"Akari net loss widens to $4.81 million in Q2 FY26; operating loss rises to $4.6 millionAkari Therapeutics posted a GAAP net loss of $4.81 million for the quarter ended June 30, 2026, widening from $1.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL84Mgx5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0167","LU0417516738.SGD","BK1589","LU0819121731.USD","LU0348825331.USD","LU1242518931.SGD","LU0181495838.USD","LU0359201612.USD","BK4007","LU0456827905.SGD","LU0516423174.USD","LU0128526141.USD","LU0359202008.SGD","LU0417516902.SGD","LU3063872942.SGD","LU0516422440.USD","BK0214","LU1242518857.USD","BK1576","02269","LU0823426308.USD","LU1688375341.USD","300615","LU0979878070.USD","LU0456846285.SGD","BK1610","LU0823426480.USD","LU0029874061.USD","LU0326950275.SGD","AKTX","LU0572944931.SGD","LU0051755006.USD","LU1794554557.SGD","LU0307460666.USD","IE00B0JY6N72.USD","LU2039709279.SGD","LU1880383366.USD","BK1141","LU1720050803.USD","LU0043850808.USD","LU0516423091.SGD","KURE","SG9999002562.SGD","BK4139","LU0708995583.HKD","LU0516422952.EUR","LU0140636845.USD","LU0320764599.SGD","LU0588546209.SGD","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658119769","title":"European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2658119769","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658119769?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:26","pubTimestamp":1786461976,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.46% to 1,966.35 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and semiconductor company Sequans Communications , which advanced 4.7% and 2.6% respectively. They were followed by telecommunications company Nokia  and medical device maker EDAP TMS , which increased 3.2% and 1.3% respectively.The decliners from continental Europe were led by brewing company Anheuser-Busch InBev  and biopharmaceutical company DBV Technologies , which dropped 3.1% and 1% respectively. They were followed by consumer goods company Unilever  and pharmaceutical company Novo Nordisk , which were off 0.9% and 1% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group  and biotech firm Autolus Therapeutics , which surged 27% and 8% respectively. They were followed by biotech company ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4169","BK4559","CLLS","LU0006061336.USD","BK4532","IE00BKVL7J92.USD","NVOX","BK4139","BK4007","BK4183","BK4592","BK4547","BUD","BK4505","DEO","OZEM","PPH","SLN","BK4141","NVO","TRIB","LU0689626769.HKD","AUTL","BK4599","MREO","BK4162","02378","LU1093756168.USD","THNR","NVOH","NOK","ULVR.UK","LU1093756325.SGD","UN","IE00BMPRXN33.USD","DGE.UK","IE00BMPRXR70.SGD","LU0154236417.USD","BK4020","PUK","DBVT","BK4082","FOCL","LU0124676726.USD","UL","IE00BZ1G4Q59.USD","LNOK","BK4585","BK4158","AKTX","SQNS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658265937","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2658265937","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658265937?lang=en_us&edition=fundamental","pubTime":"2026-08-10 23:16","pubTimestamp":1786374966,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.14% to 1,959.77 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by furniture maker Natuzzi  and petroleum refiner Equinor , which advanced 17% and 3.8% respectively. They were followed by biopharmaceutical company DBV Technologies  and biotech firm Evaxion , which rose 3.6% and 2.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and internet advertising firm Criteo , which fell 3.4% and 2.3% respectively. They were followed by accommodations booking site trivago  and brewing company Anheuser-Busch InBev , which were down 1.7% and 1.3% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Akari Therapeutics , which surged 43% and 7.7% respectively. They were followed by oil and gas company BP  and biotech ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLLS","AKTX","BUD","BK4075","BP","BUD.AU","LU0300736062.USD","BK4077","BTI.AU","BK4107","BPH","TRVG","EVAX","LU1162221912.USD","BK4007","EQNR","IE00BFMHRM44.USD","BK4139","BK4117","TRIB","BK4201","LU1829250122.USD","NICO","CRTO","WPP.AU","BK7062","LU0006061336.USD","LU0162691827.USD","LU0320765646.SGD","BK4532","NTZ","VOD","BK4158","DBVT","BK4095","BK4132","BK4082","SLN","LU2543165471.USD","EPV","AFG","LU0300736492.USD","BTI","BK4585","WPP","BK4588","BK7119","LU0072461881.USD","IEUR","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657762955","title":"Akari Therapeutics PLC Expected to Post a Loss of $1.40 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657762955","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657762955?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:57","pubTimestamp":1786136225,"startTime":"0","endTime":"0","summary":"Akari Therapeutics PLC <AKTX.OQ> expected to post a loss of $1.40 a share - Earnings PreviewAkari Therapeutics PLCAKTX.OQAKTX.Ois expected to  report resultson August 11 (estimated) for the period end","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559896","title":"Akari Therapeutics Enters Research Collaboration with WhiteHawk Therapeutics on Dual-Payload ADCs","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559896","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656559896?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:50","pubTimestamp":1785847820,"startTime":"0","endTime":"0","summary":"Akari Therapeutics enters research collaboration with WhiteHawk Therapeutics on dual-payload ADCsAkari Therapeutics entered a strategic research collaboration with WhiteHawk Therapeutics to evaluate a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL54b9S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","BK4139","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","AKTX","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4007","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","BCDF","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656701883","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2656701883","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656701883?lang=en_us&edition=fundamental","pubTime":"2026-08-03 23:05","pubTimestamp":1785769539,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week off lower late Monday morning, declining 0.35% to 1,925.58 on the S&P Europe Select ADR Index.From continental Europ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IXC","GUSH","WTIU","BK4139","AKTX","LU2324357040.USD","TBXU","ERX","DBE","BDRX","VDE","PXE","XES","E","AUTL","DIG","FMED","MTLS","PXJ","AZNH","SAP","LU0006061336.USD","TRIB","IEUR","EQNR","NCNA","EPV","LU2462157665.USD","BPH","BK4554","BP","AZN","BK7119","DRIP","PRNT","USE","ERIC","BUD","BUD.AU","TRVG","LU2237443382.USD","DBC","ARGX","DRLL","AFG","IBB","SLN","FTXN","LU0310800379.SGD","IEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655809013","title":"European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2655809013","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655809013?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:15","pubTimestamp":1785424552,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking sharply higher late Thursday morning, rising 1.84% to 1,938.04 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and lender ING Group , which advanced 9.8% and 7% respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria  and Banco Santander , which climbed 6.8% and 4.6% respectively.The decliners from continental Europe were led by pharmaceutical company Sanofi  and software firm SAP , which lost 6.2% and 2.8% respectively. They were followed by internet ad firm Criteo  and biopharmaceutical company argenx , which dropped 2.5% and 1.8% respectively.The gainers from the UK were led by lenders Barclays  and Lloyds Banking Group , which rose 5.6% and 5.4% respectively. They were followed by insurance firm Prudential  and biopharmaceutical company Mereo BioPharma Group , which were up 4.8% and 1.6% respectively.The decliners","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","GSIB","DAVA.AU","WPP.AU","BK4505","LNOK","LU0320765992.SGD","ING.AU","AFG","LU0084288595.USD","SNY","TRIB","LYG","SAN.AU","LU0109394709.USD","MREO","SAP","ARGX","BK4007","TBXU","BK4139","IE00BJJMRZ35.SGD","NOK","BCS","IE0034235188.USD","IE00B2B36J28.USD","IEUR","EPV","BK4134","BK7505","PUK","ING","SAN","BK4020","BK4547","IBB","WPP","FMED","IE00BMPRXN33.USD","IE00BFTCPJ56.SGD","BK4009","BK7141","LU1983260115.SGD","IE0009355771.USD","AKTX","CRTO","BBVA","BK4588","DAVA","IE00BMPRXR70.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655891767","title":"European Equities Traded in US as ADRs Ease in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2655891767","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655891767?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:05","pubTimestamp":1785337507,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts eased late Wednesday morning with the S&P Europe Select ADR Index down 0.1% to 1,906.06.From continental Europe, the gainers were led by oil and gas company Eni  and energy company Equinor , which climbed 6.9% and 6.2%, respectively. They were followed by software firm SAP  and travel-booking company trivago , which increased 3% and 2.6%, respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and telecommunications company Nokia , which fell 4.8% and 3.6%, respectively. They were followed by lenders Banco Santander  and Banco Bilbao Vizcaya Argentaria , which dropped 2.5% and 2.3%, respectively.The gainers from the UK were led by software firm Endava  and oil and gas company BP , which rose 4.2% and 3.7%, respectively. They were followed by oil and gas company Shell  and biopharmaceutical company Amarin , which climbed 2.5% and 2.4%, respectively.The decliners from t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EQNR","GUSH","BCS","BBVA","XES","EPV","SLN","DRIP","LU0006061336.USD","LU0162691827.USD","LNOK","SHEL","DIG","DBE","WTIU","SQNS","LU0648005311.SGD","BP","DBC","SAP","GSIB","IEO","SHEH","VDE","IXC","BPH","TRVG","SAN","SCHY","NOK","AMRN","DAVA.AU","BK4585","DAVA","BK4588","SAN.AU","ERX","DRLL","BK4521","PXE","USE","FTXN","BDRX","IEUR","AKTX","PXJ","BK4613","E","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654496240","title":"European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2654496240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654496240?lang=en_us&edition=fundamental","pubTime":"2026-07-27 23:13","pubTimestamp":1785165187,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week slightly higher late Monday morning, rising 0.15% to 1,910.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP  and lender Banco Santander , which rose 6% and 3.5% respectively. They were followed by biotech firm Evaxion  and biopharmaceutical company Grifols , which increased 3.3% and 3.2% respectively.The decliners from continental Europe were led by petroleum refiner Equinor  and oil and gas company Eni , which fell 3% and 2.6% respectively. They were followed by brewing company Anheuser-Busch InBev  and biopharmaceutical company argenx , which were down 1.8% and 0.7% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and telecommunications operator Vodafone Group , which climbed 9.6% and 5.4% respectively. They were followed by biotech firm Autolus Therapeutics  and pharmaceutical company Silence Therape","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XES","WTIU","BP","BUD","BTI.AU","SAN","SHEH","E","ARGX","IBB","SHEL","VDE","PXJ","AFG","DRIP","FMED","DRLL","IEO","USE","ERX","SAP","TBXU","SAN.AU","FTXN","NICO","DBE","EQNR","BK4588","NGG","IXC","LU0278409577.USD","EPV","BUD.AU","GUSH","AKTX","DIG","EVAX","GRFS","PXE","IE00BJJMRZ35.SGD","SLN","VOD","BK4023","AUTL","DBC","IEUR","BPH","GSIB","BTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653769130","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2653769130","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653769130?lang=en_us&edition=fundamental","pubTime":"2026-07-22 23:10","pubTimestamp":1784733024,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.69% to 1,924.81 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and petroleum refiner Equinor , which climbed 6.8% and 4.9%, respectively. They were followed by semiconductor company Sequans Communications  and brewing company Anheuser-Busch InBev , which advanced 4% and 2.8%, respectively.The decliners from continental Europe were led by internet browser company Opera  and biopharmaceutical company DBV Technologies , which dropped 3.3% and 2.9%, respectively. They were followed by telecommunications company Nokia  and software firm SAP , which lost 2.6% and 2%, respectively.The gainers from the UK were led by biopharmaceutical firm Akari Therapeutics  and insurance firm Prudential , which rose 6.6% and 3.4%, respectively. They were followed by lender HSBC  and telecommunications company operato","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDRX","BUD.AU","LU0128525689.USD","LU0496365809.HKD","BK4023","BK4532","IE00BMPRXR70.SGD","LNOK","TRIB","BK4588","DBVT","HSBH","SLN","BK4139","BK4201","HSBC","IE00BMPRXN33.USD","EPV","BK4158","VOD","SQNS","BK4207","BK4132","BK4117","BK4521","AFG","SAP","EQNR","BK4020","LU0211326755.USD","CLLS","LU2236285917.USD","OPRA","PSO","LU0052756011.USD","NOK","BK4082","AKTX","LU0976567544.SGD","BK4204","LU0211326839.USD","LFGY","BK4107","BK4141","PUK","LU0310800965.SGD","IEUR","BK4162","BUD","BK4528"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653768898","title":"Akari Therapeutics Enters Strategic ADC Payload Research Collaboration with Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653768898","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653768898?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:40","pubTimestamp":1784724025,"startTime":"0","endTime":"0","summary":"Akari Therapeutics enters strategic ADC payload research collaboration with Whitehawk TherapeuticsAkari Therapeutics entered a strategic research collaboration with Whitehawk Therapeutics to evaluate ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL81G8CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4007","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","AKTX","SG9999014021.USD","BK4588","NDAQ","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014039.USD","BCDF","BK4139","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653711942","title":"Akari Therapeutics Enters Preclinical ADC Research Collaboration with Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653711942","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653711942?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:06","pubTimestamp":1784632000,"startTime":"0","endTime":"0","summary":"Akari Therapeutics enters preclinical ADC research collaboration with Whitehawk TherapeuticsAkari Therapeutics entered a strategic research collaboration with Whitehawk Therapeutics to run preclinical","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDLZ5M5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00B64PRP62.GBP","AKTX","IE00BGHQF748.EUR","BK4588","IE00BN0W2T93.GBP","LU2095319765.USD","BK4112","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4007","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BK4139","LU2210150020.SGD","SG9999014021.USD","BCDF","LU0314104364.USD","SG9999014039.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653719702","title":"Akari Therapeutics - Collaboration to Commence Immediately with Interim Data Updates Anticipated","url":"https://stock-news.laohu8.com/highlight/detail?id=2653719702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653719702?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:05","pubTimestamp":1784631900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA9N8JS8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AKTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653719052","title":"Akari Therapeutics - Co and Whitehawk to Conduct Preclinical Studies of Ph1 Payload with Top1i ADC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2653719052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653719052?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:05","pubTimestamp":1784631900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA9N8JS8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AKTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akaritx.com","stockEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.317},{"period":"3month","weight":1.0107},{"period":"6month","weight":-0.2167},{"period":"1year","weight":-0.8138},{"period":"ytd","weight":-0.3495}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0395},{"period":"3month","weight":0.0531},{"period":"6month","weight":0.1259},{"period":"1year","weight":0.2008},{"period":"ytd","weight":0.1331}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.007289},{"month":2,"riseRate":0.25,"avgChangeRate":-0.164819},{"month":3,"riseRate":0.384615,"avgChangeRate":0.051328},{"month":4,"riseRate":0.461538,"avgChangeRate":0.052868},{"month":5,"riseRate":0.230769,"avgChangeRate":0.014482},{"month":6,"riseRate":0.461538,"avgChangeRate":0.016983},{"month":7,"riseRate":0.307692,"avgChangeRate":0.004368},{"month":8,"riseRate":0.461538,"avgChangeRate":0.210227},{"month":9,"riseRate":0.5,"avgChangeRate":0.047326},{"month":10,"riseRate":0.25,"avgChangeRate":-0.130903},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.07207},{"month":12,"riseRate":0.25,"avgChangeRate":-0.096768}],"exchange":"NASDAQ","name":"Akari Therapeutics PLC","nameEN":"Akari Therapeutics PLC","securityTypeName":"DR","adrRate":"1:2000"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Akari Therapeutics PLC,AKTX,Akari Therapeutics PLC股票,Akari Therapeutics PLC股票老虎,Akari Therapeutics PLC股票老虎国际,Akari Therapeutics PLC行情,Akari Therapeutics PLC股票行情,Akari Therapeutics PLC股价,Akari Therapeutics PLC股市,Akari Therapeutics PLC股票价格,Akari Therapeutics PLC股票交易,Akari Therapeutics PLC股票购买,Akari Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction